Lowe`s Companies Inc vs Nuvalent Inc — how do they compare? Lowe`s Companies Inc trades at $204.71 (market cap $114.78B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Lowe`s Companies Inc is far larger — about 11.7× Nuvalent Inc's market cap, and Lowe`s Companies Inc pays a 2.44% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| LOW | NUVL | |
|---|---|---|
Market Cap | $114.78B | $9.81B |
Sector | Consumer Cyclical | Technology |
52-Week High | $287.39 | $123.96 |
52-Week Low | $204.76 | $72.16 |
Enterprise Value | $156.54B | $8.52B |
Dividend Yield | 2.44% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nuvalent (NUVL) trades at $123.96, unchanged on the day, with a bullish technical signal from moving averages but overbought oscillators. The company reported a net loss of $425.38 million for 2025 and negative cash flow from operations. Recent news is dominated by GSK's proposed acquisition of Nuvalent for $124 per share, announced in June 2026, which is under investigation by multiple law firms for fairness to shareholders.
The investment outlook is heavily influenced by the pending acquisition. While analyst consensus shows no sell ratings, the stock price is near the offer price, limiting upside. Key risks include the deal's completion and the company's ongoing losses. The primary opportunity is the acquisition premium, but fundamental challenges persist absent the deal.
Trailing returns across standard periods
Latest headlines on both assets
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →